Amalgamated Bank Vanda Pharmaceuticals Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,887 shares of VNDA stock, worth $8,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,887
Previous 1,887
-0.0%
Holding current value
$8,265
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VNDA
# of Institutions
152Shares Held
43.9MCall Options Held
13.8KPut Options Held
1.01M-
Black Rock Inc. New York, NY8.14MShares$35.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$15.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$15.1 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$13.7 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$11.2 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $248M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...